Does Rhonda Patrick recommend Quercetin?
Yes — Rhonda Patrick has directly recommended Quercetin.
Published research rates it weak evidence. Of Rhonda Patrick's 79 tracked claims, 22 are supported or partially supported by studies on PubMed.
Evidence last reviewed May 2026
Rhonda Patrick on Quercetin — 79 claims
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.
None of the 10 retrieved studies provide extractable key findings, populations, or limitations, making it impossible to directly evaluate the specific dose range of 250–500 mg of a bioavailable querce…
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.
None of the 10 retrieved studies provide extractable key findings, population data, or dose-specific details that directly evaluate the 250–500 mg quercetin range for daily anti-inflammatory or antiox…
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.
The available evidence provides indirect support for the 250–500 mg range as a reasonable dosing window. The safety review (PMID: 29127724) notes that quercetin supplements are commonly marketed at do…
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.
None of the 10 retrieved studies provide specific key findings, populations, or limitations data that can be directly evaluated, making it impossible to confirm or contradict the specific dose range (…
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable quercetin formulation are more typical.
The research literature supports quercetin's anti-inflammatory and antioxidant properties broadly, and the safety review (PMID: 29127724) and therapeutic potential review (PMID: 38258783) note that qu…
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.
The 10 provided studies — spanning reviews, systematic reviews, and one meta-analysis — contain no extractable key findings, populations, or limitations as presented, making direct comparison impossib…
“Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.”
Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.
None of the 10 retrieved studies directly address the bioavailability of quercetin phytosome formulations compared to standard quercetin, nor do any report a specific '20-fold higher bioavailability'…
“It's been studied for decades as an antioxidant and anti-inflammatory”
Quercetin has been studied for decades as an antioxidant and anti-inflammatory.
The claim that quercetin has been studied for decades as an antioxidant and anti-inflammatory is well-supported by the breadth and diversity of the provided literature. Multiple review articles (e.g.,…
“the most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.”
The most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.
None of the 10 provided studies directly address quercetin's senolytic activity or its ability to selectively eliminate senescent cells. The retrieved literature covers quercetin's effects on inflamma…
“The work from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.”
Research from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.
None of the 10 provided studies address the specific claim about quercetin combined with dasatinib as a senolytic agent targeting senescent cells in mice or humans from James Kirkland's lab at Mayo Cl…
“The human trials showing that senolytic treatment reduced senescent cell burden and improved physical function are genuinely groundbreaking.”
Human trials have shown that senolytic treatment with quercetin (and dasatinib) reduced senescent cell burden and improved physical function.
None of the 10 provided studies directly address the specific claim that senolytic treatment with quercetin and dasatinib reduces senescent cell burden or improves physical function in humans. The ret…
“the protocols used in research typically involve intermittent high-dose administration — for example, 500 milligrams twice daily for two to three days, then a gap of weeks to months — rather than daily low-dose supplementation.”
For senolytic purposes, research protocols typically use intermittent high-dose administration — 500 milligrams twice daily for two to three days, followed by a gap of weeks to months — rather than daily low-dose supplementation.
None of the 10 provided studies directly address senolytic dosing protocols for quercetin or any compound. The studies cover topics such as inflammation, bone metabolism, cardiovascular risk, rheumato…
“Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.”
Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.
None of the 10 retrieved studies directly evaluate quercetin phytosome formulations or provide specific bioavailability comparisons between phytosome and standard quercetin forms. While PMID 40037045…
“The human trials showing that senolytic treatment reduced senescent cell burden and improved physical function are genuinely groundbreaking.”
Human trials have shown that senolytic treatment with quercetin (and dasatinib) reduced senescent cell burden and improved physical function.
None of the 10 provided studies directly address the claim about senolytic treatment with quercetin and dasatinib reducing senescent cell burden or improving physical function in human trials. The ret…
“The human trials showing that senolytic treatment reduced senescent cell burden and improved physical function are genuinely groundbreaking.”
Human trials have shown that senolytic treatment with quercetin (and dasatinib) reduced senescent cell burden and improved physical function.
None of the 10 provided studies directly address the claim about senolytic treatment with quercetin (and dasatinib) reducing senescent cell burden or improving physical function in humans. The retriev…
“It's been studied for decades as an antioxidant and anti-inflammatory”
Quercetin has been studied for decades as an antioxidant and anti-inflammatory.
The claim that quercetin has been studied for decades as an antioxidant and anti-inflammatory is supported by the breadth and diversity of the provided literature. Multiple systematic reviews and meta…
“Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.”
Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.
None of the 10 provided studies directly examine quercetin phytosome formulations or report bioavailability comparisons between phytosome and standard quercetin forms. While PMID 40037045 is a systema…
“It's been studied for decades as an antioxidant and anti-inflammatory”
Quercetin has been studied for decades as an antioxidant and anti-inflammatory.
The expert's claim that quercetin has been studied for decades as an antioxidant and anti-inflammatory is supported by the breadth and diversity of the provided literature, which spans reviews, meta-a…
“the most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.”
The most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.
None of the 10 retrieved studies address quercetin's senolytic activity — the specific mechanism claimed by Rhonda Patrick involving selective elimination of senescent cells. The available literature…
“the protocols used in research typically involve intermittent high-dose administration — for example, 500 milligrams twice daily for two to three days, then a gap of weeks to months — rather than daily low-dose supplementation.”
For senolytic purposes, research protocols typically use intermittent high-dose administration — 500 milligrams twice daily for two to three days, followed by a gap of weeks to months — rather than daily low-dose supplementation.
None of the 10 provided studies address senolytic dosing protocols for quercetin. The studies cover topics such as allergy, bioavailability, exercise recovery, blood pressure, diabetes, endometriosis,…
Other supplements Rhonda Patrick discusses
Claims are extracted from publicly available podcasts and videos, attributed to their source, and compared against PubMed research. This is educational information only — consult a healthcare provider before starting any supplement.
Back to Rhonda Patrick